Purchase Order 75N90021P00233
Award Date
2/25/21
Potential Completion Date
2/28/23
Potential Value
$138K
Federal Agency
NIH Clinical Center
Awardee
Bioarray Solutions LTD
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Warren, NJ 07059, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract worth $148,270.80 to Bioarray Solutions LTD, a for-profit manufacturer, to provide transfusion medicine reagents. The contract has a period of performance through January 30, 2021 and does not have a set-aside designation. Bioarray Solutions LTD is the sole manufacturer and trademark holder of the proprietary reagents required for the NIH Clinical Center's existing BioArray Imaging...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Bioarray Solutions LTD, a for-profit manufacturer, to provide bioarray reagents. The contract has a ceiling value of $40,660.58 and a period of performance ending on January 31, 2019. This award is not set aside and is one of multiple prime contracts that Bioarray Solutions has received from the NIH Clinical Center in recent years to provide a range of products and services in...
This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Bioarray Solutions Ltd., a for-profit manufacturer registered in SAM.gov. The contract, with a ceiling value of $79,504.00, is for the provision of laboratory equipment and supplies, and has an ultimate completion date of September 21, 2023. The contract was not set aside for any specific business type. Bioarray Solutions has been awarded multiple prime contracts from the NIH...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $198,597.49 firm-fixed-price purchase order contract to Life Technologies Corporation, a for-profit manufacturer, to supply specialized reagents and disposables to support the NIH's cellular therapy research and treatment programs. The contract is for a base year with three option years, providing reagents and supplies to enable the processing of approximately 100 cellular therapy...
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $266,475.00 order was for a NextSeq 550 Sequencing System, shipping, maintenance, software licenses, and technical support to support the NIH Clinical Center's Department of Transfusion Medicine and its blood collection and research activities. The contract was...
This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to BioMérieux Inc. for the supply of reagents and supplies for the BioMérieux BacT/ALERT Dual-T instrument. The $135,626.70 contract supports the Department of Laboratory Medicine at the NIH Clinical Center, which provides laboratory support for patient care and research. The reagents are required to conduct sterility testing on cell therapy products to ensure patient safety...
This delivery order for $18,919.38 was awarded against the Department of Health and Human Services' National Institutes of Health Clinical Center's master GSA Schedule contract for invitro diagnostics, reagents, and tests. It is for reagents needed by the Department of Transfusion Medicine at the Clinical Center for patient and donor testing, to be delivered by February 2023. The prime contractor is Quotient Biodiagnostics, Inc. located in Newtown, Pennsylvania. No set-aside designation was used...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a Firm Fixed Price purchase order to Becton, Dickinson and Company (BD), a manufacturer of medical devices, instruments, and reagents. The $38,920.00 contract is for BD reagents to be used for single-cell abseq analysis on BD Rhapsody instruments in the PACT section of the Clinical Center. The contract has an August 30, 2024 completion date and was awarded on May 15, 2024. This purchase order is not...
The Department of Health and Human Services' National Institutes of Health Clinical Center awarded a firm fixed-price purchase order to Omixon, Inc., a foreign-owned for-profit organization, to provide reagents in support of the NIH Clinical Center's research and development activities related to HLA testing and transplantation. The contract, valued at $101,220.00, did not utilize any set-aside programs. Omixon, as the prime contractor, has previously provided the NIH Clinical Center with...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,070.00 firm fixed price purchase order to Global Life Sciences Solutions USA LLC for CT-300.1 SEFIA CELL PROCESSING KITS. This order does not have a set-aside designation. The contract is for the delivery of 8 units by May 30, 2024. Global Life Sciences Solutions USA LLC is a for-profit limited liability company that manufactures goods and has previously provided scientific equipment,...